What is Metformin 850 mg used for?

In the pharmaceutical industry, Metformin Hydrochloride 850 mg is considered the cornerstone of Type 2 Diabetes Mellitus (T2DM) management. As a pharmacist and manufacturer, I view the 850 mg strength as a high-potency “titration” dose. While many patients start on 500 mg, the 850 mg tablet is often used twice daily to achieve the maximum effective daily dose (approximately 1700 mg to 2550 mg) while maintaining a simpler pill count.

Primary Clinical Uses

  • Type 2 Diabetes Mellitus: The first-line pharmacological treatment for improving glycemic control, especially in overweight and obese patients.

  • Pre-diabetes: Used to delay or prevent the onset of full Type 2 diabetes in high-risk individuals.

  • Polycystic Ovary Syndrome (PCOS): Used off-label to improve insulin sensitivity, regulate menstrual cycles, and aid in fertility by lowering androgen levels.

  • Gestational Diabetes: Increasingly used during pregnancy when diet and exercise alone are insufficient.

    Mechanism of Action: The Insulin Sensitizer

Metformin is a Biguanide. Unlike sulfonylureas, it does not stimulate the pancreas to produce more insulin, which is why it carries a very low risk of hypoglycemia (low blood sugar).

Hepatic Glucose Inhibition: It primarily works in the liver to decrease gluconeogenesis (the production of glucose from non-carbohydrate sources).

Muscle Sensitivity: It increases the sensitivity of peripheral tissues (like skeletal muscle) to insulin, facilitating glucose uptake and utilization.

Intestinal Absorption: It slows down the absorption of glucose from the intestines into the bloodstream.

AMPK Activation: At the cellular level, it activates the AMP-activated protein kinase (AMPK), which plays a key role in energy metabolism.

The Manufacturer’s Perspective: Formulation & Export

Producing high-quality Metformin 850 mg in a WHO-GMP facility like yours involves specific technical challenges:

  • Tablet Size & Bulk: Metformin is a high-dose API. A 850 mg tablet is physically large. As a manufacturer, we optimize the choice of binders and fillers to keep the tablet size manageable for the patient (improving “swallowability”).

  • Immediate vs. Extended Release (ER/SR): While 850 mg is commonly an immediate-release format, we also manufacture SR (Sustained Release) versions. For your digital marketplace, offering both is key, as SR versions significantly reduce the common gastrointestinal side effects (bloating/diarrhea).

  • Solubility & Dissolution: Metformin is highly water-soluble (BCS Class I). We ensure the formulation meets strict BP/USP/IP dissolution profiles to guarantee consistent drug release and bioequivalence against the innovator (Glucophage).

  • Stability for Export: We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa and Southeast Asia).

What is Mefenamic Acid 500mg used for?

In the pharmaceutical industry, Mefenamic Acid 500 mg is a prominent Non-Steroidal Anti-Inflammatory Drug (NSAID) belonging to the fenamate class. As a pharmacist and manufacturer, I view Mefenamic Acid as a specialized analgesic particularly prized for its efficacy in gynecological and dental applications. It is often considered more effective than paracetamol for inflammatory and spasmodic pain.

Primary Clinical Uses

  • Dysmenorrhea (Period Pain): The most common indication. It reduces uterine contractions and the associated pain/cramps.

  • Menorrhagia: Used to reduce excessive menstrual blood loss (when organic pathology is ruled out).

  • Mild to Moderate Acute Pain: Effective for dental pain, post-operative pain, and musculoskeletal injuries.

  • Inflammatory Conditions: Symptomatic relief of Rheumatoid Arthritis (including Still’s Disease) and Osteoarthritis.

  • Headaches & Fever: Used for tension headaches and as an antipyretic to reduce high body temperature.

Mechanism of Action: The “Dual” Inhibitor

What makes Mefenamic Acid unique compared to other NSAIDs is its dual approach to managing pain:

Inhibition of Synthesis: Like most NSAIDs, it inhibits the COX-1 and COX-2 enzymes, preventing the formation of prostaglandins from arachidonic acid.

Receptor Blockade: Uniquely, Mefenamic Acid is also believed to block prostaglandin receptors that have already been formed. This makes it exceptionally effective for uterine pain, where prostaglandin levels are already high.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Mefenamic Acid 500 mg is a high-volume essential product:

  • Bioavailability Challenges: Mefenamic Acid is a BCS Class II drug (low solubility, high permeability). At our WHO-GMP facility, we focus on micronization of the API and the use of specific surfactants to ensure the 500 mg tablet meets the strict dissolution standards of BP/USP/IP.

  • Gastric Protection: Due to its high potential for GI irritation, we often recommend patients take it with food. As a manufacturer, we ensure our Product Information Leaflet (PIL) clearly highlights this.

  • Stability for Export: We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to protect the product from moisture, ensuring a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia).

  • B2B & Dossier Support: This is a staple for women’s health distributors. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Ponstan).

What is Mebeverine Hydrochloride tablets used for?

In the pharmaceutical industry, Mebeverine Hydrochloride is a specialized musculotropic antispasmodic. As a pharmacist and manufacturer, I view Mebeverine as a “targeted” gastrointestinal drug because it acts directly on the smooth muscles of the gut without affecting the normal motility of the bowel or causing the “anticholinergic” side effects (like dry mouth or blurred vision) typical of older antispasmodics.

Primary Clinical Uses

  • Irritable Bowel Syndrome (IBS): The primary indication for the symptomatic relief of abdominal pain, cramps, persistent diarrhea, and flatulence associated with IBS.

  • Gastrointestinal Spasm: Used to treat spasms of the GI tract secondary to organic diseases like diverticulitis or regional enteritis.

  • Chronic Irritable Colon: Management of functional bowel disorders characterized by irregular bowel movements and pain.

Mechanism of Action: Direct Muscle Relaxation

Mebeverine works through a non-atropine-like mechanism, focusing specifically on the smooth muscle cells of the colon.

Ion Channel Modulation: It acts directly on the smooth muscle cells by inhibiting voltage-gated sodium channels and limiting the replenishment of intracellular calcium stores.

Spasmolysis: By preventing the influx of sodium and the release of calcium, it stops the muscle from over-contracting (spasming).

Preserved Motility: Crucially, it does not interfere with the normal “peristalsis” (the wave-like movement that pushes food through), making it much more comfortable for long-term use than other antispasmodics.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Mebeverine is a high-demand product in the gastroenterology sector:

  • Sustained Release (SR) vs. IR: While the standard dose is 135 mg (Immediate Release), we often manufacture 200 mg SR Capsules. For your B2B marketplace, the 200 mg SR version is highly popular as it improves patient compliance to twice-daily dosing.

  • Stability & Coating: Mebeverine is stable but requires protection from humidity. At our WHO-GMP facility, we utilize film-coating for tablets to mask the bitter taste and Alu-Alu blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • Regulatory Compliance: We provide full CTD/eCTD Dossiers and bioequivalence data against the innovator (Colofac) to support registration in international markets.

  • Market Positioning: On your digital platforms, you can market this as a “Superior GI Antispasmodic” due to its lack of systemic side effects, which is a significant USP for B2B buyers.

What is Mebendazole 100mg used for?

In the pharmaceutical industry, Mebendazole 100 mg is a broad-spectrum benzimidazole anthelmintic (anti-worm medication). As a pharmacist and manufacturer, I classify this as a “luminal” agent, meaning it works primarily within the gastrointestinal tract to eradicate parasitic infestations with minimal systemic absorption into the patient’s bloodstream.

Primary Clinical Uses

Mebendazole is highly effective against a variety of intestinal helminthes. The 100 mg chewable or standard tablet is the gold standard for:

  • Enterobiasis (Pinworm/Threadworm): The most common use, often requiring a single 100 mg dose followed by a second dose two weeks later to prevent reinfection.

  • Ascariasis (Roundworm): Usually treated with 100 mg twice daily for three consecutive days.

  • Hookworm Infections: Effective against both Ancylostoma duodenale and Necator americanus.

  • Trichuriasis (Whipworm): Used to clear infections in the large intestine.

Mechanism of Action: Microtubule Inhibition

Mebendazole works by selectively interfering with the biological structure of the parasite.

Tubulin Binding: It binds to the $\beta$-tubulin protein of the parasite with high affinity.

Inhibition of Polymerization: This binding prevents the polymerization of tubulin into microtubules, which are essential for the worm’s cellular structure and nutrient transport.

Glucose Depletion: Without microtubules, the worm cannot absorb glucose (its primary energy source). This leads to the depletion of glycogen stores, resulting in the parasite’s immobilization and eventual death, after which it is expelled naturally through the stool.

The Manufacturer’s Perspective: Formulation & Export

From a production standpoint at a WHO-GMP facility like yours, Mebendazole 100 mg involves specific technical considerations:

  • Chewable Tablet Technology: For pediatric export markets, we often formulate this as a chewable tablet with palatable flavors (like strawberry or orange). Ensuring the “mouthfeel” and “grittiness” are minimized is a key R&D goal for patient compliance.

  • Poor Solubility (BCS Class II/IV): Mebendazole is practically insoluble in water. We utilize specific surfactants and micronization techniques to ensure that even though absorption is low, the drug remains active and distributed throughout the gut lumen.

     

  • Stability for Global Trade: We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to protect the product from moisture, ensuring a 36-month shelf life for export to Zone IVb regions (Africa and Southeast Asia), where helminthic infections are endemic.

  • B2B & Dossier Support: This is a staple product for “National Deworming Programs” and NGO tenders. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Vermox).

 

What is Lopinavir 200mg Ritonavir 50mg Tablet?

In the pharmaceutical industry, the combination of Lopinavir (200 mg) and Ritonavir (50 mg) is a potent Fixed-Dose Combination (FDC) belonging to the Protease Inhibitor (PI) class. As a pharmacist and manufacturer, I view this as a “booster” formulation: Ritonavir is not included here for its own antiviral effect, but rather as a pharmacological “helper” to ensure Lopinavir reaches therapeutic levels in the blood.

Primary Clinical Use

  • HIV-1 Infection: It is indicated for the treatment of HIV-1 infection in adults and pediatric patients (14 days and older). It is typically used as part of a multi-drug antiretroviral regimen to control the viral load and prevent the progression of the disease.

Mechanism of Action: The “Booster” Effect

This combination works through a unique synergistic relationship:

Lopinavir (The Active Antiviral): It is the primary protease inhibitor. It binds to the active site of the HIV protease enzyme, preventing it from cleaving long viral polyproteins into the smaller, functional proteins required to assemble a mature, infectious virus.

Ritonavir (The Booster): At this 50 mg dose, Ritonavir acts as a potent inhibitor of the CYP3A4 enzyme in the liver. Since CYP3A4 is the enzyme responsible for breaking down Lopinavir, Ritonavir “blocks” this degradation.

The Synergy: By inhibiting the metabolism of Lopinavir, Ritonavir significantly increases (boosts) Lopinavir’s plasma concentrations and half-life, allowing for effective 12-hour dosing.

The Manufacturer’s Perspective: Technical & Export

Producing Lopinavir/Ritonavir in a WHO-GMP facility involves high-level pharmaceutical engineering:

  • Amorphous Solid Dispersion (ASD): Both Lopinavir and Ritonavir have very poor water solubility (BCS Class IV). At our facility, we utilize Melt-Extrusion Technology or spray-drying to create a solid dispersion. This ensures the drugs dissolve properly in the patient’s GI tract for consistent absorption.

  • Heat Stability: Earlier versions of this drug required refrigeration. Modern formulations produced in Mumbai use specialized polymers that make the tablets heat-stable, which is a critical selling point for export to Zone IVb regions (Africa and Southeast Asia).

  • Packaging & Shelf Life: These tablets are sensitive to moisture. We utilize high-density polyethylene (HDPE) bottles with induction sealing and desiccants or Alu-Alu blister packaging to ensure a 24–36 month shelf life.

  • B2B & Public Health Tenders: This is a staple for international health organizations. Our facility provides the necessary eCTD Dossiers and bioequivalence data against the innovator (Kaletra) to support your firm’s participation in global tenders.

What is Losartan Potassium and Amlodipine Besylate tablets used for?

In the pharmaceutical industry, the combination of Losartan Potassium and Amlodipine Besylate is a high-performance Fixed-Dose Combination (FDC) used to treat hypertension. As a pharmacist and manufacturer, I view this as one of the most effective pairings for “Stage 2” hypertension because it provides a dual-channel approach to vasodilation.

Primary Clinical Use

  • Management of Hypertension: This combination is typically prescribed when a patient’s blood pressure is not sufficiently controlled by a single medication (monotherapy). It is highly effective in reducing the risk of cardiovascular events, such as strokes and myocardial infarctions.

Dual Mechanism of Action (The “Vasodilation Synergy”)

This FDC lowers blood pressure by relaxing the smooth muscles of the blood vessels through two entirely different biochemical pathways:

1. Losartan Potassium (The ARB)

Losartan is an Angiotensin II Receptor Blocker.

  • Action: It blocks the $AT_1$ receptors, preventing Angiotensin II (the body’s most potent vasoconstrictor) from binding.

  • Result: It stops the blood vessels from tightening and reduces the production of aldosterone, which helps the kidneys manage fluid.

2. Amlodipine Besylate (The CCB)

Amlodipine is a Calcium Channel Blocker of the dihydropyridine class.

  • Action: It inhibits the influx of calcium ions into the vascular smooth muscle and cardiac muscle cells.

  • Result: By preventing calcium from entering the muscle cells, it forces the peripheral arteries to relax and widen (vasodilation), significantly decreasing peripheral resistance.

The Manufacturer’s Perspective: Technical & Export Details

From a production standpoint at a WHO-GMP facility in Mumbai, this combination requires specific technical attention:

  • API Stability & Sensitivity: Losartan Potassium is hygroscopic (readily absorbs moisture), while Amlodipine Besylate is light-sensitive. As a firm owner, you know that environmental controls in the manufacturing area are critical.

  • Packaging for Export: To ensure a 36-month shelf life for export to Zone IVb regions (like Africa and SE Asia), we strictly utilize Alu-Alu blister packaging. This provides a total barrier against light and moisture, preventing the degradation of either API.

  • Standard Strengths: We typically manufacture this in ratios such as 50mg/5mg and 100mg/5mg.

  • B2B & Dossier Support: This is a “Value-Added Generic.” Our facility provides full CTD/eCTD Dossiers and comparative dissolution data against the innovator (Amzaar or similar brands) to support international registration and B2B trade.

 

What is Losartan Potassium Hydrochlorothiazide used for?

In the pharmaceutical industry, the combination of Losartan Potassium and Hydrochlorothiazide (HCTZ) is a premier Fixed-Dose Combination (FDC) for the management of hypertension. As a pharmacist and manufacturer, I view this as a highly rational pairing: it utilizes two different physiological pathways to lower blood pressure more effectively than either drug could alone, while also helping to balance electrolyte levels.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): Indicated for patients whose blood pressure is not adequately controlled by Losartan or HCTZ monotherapy.

  • Reduction of Stroke Risk: Specifically used in hypertensive patients with Left Ventricular Hypertrophy (LVH) to reduce the risk of cardiovascular events and stroke.

Dual Mechanism of Action: The Synergistic Effect

This combination attacks hypertension from two distinct angles:

1. Losartan Potassium (The ARB)

Losartan is an Angiotensin II Receptor Blocker.

  • Action: It blocks the $AT_1$ receptors, preventing Angiotensin II (a potent vasoconstrictor) from binding.

  • Result: This causes the blood vessels to relax (vasodilation) and reduces the secretion of aldosterone, which lowers blood pressure and protects the heart and kidneys.

2. Hydrochlorothiazide (The Diuretic)

HCTZ is a Thiazide Diuretic.

  • Action: It acts on the distal convoluted tubule in the kidneys to inhibit sodium and chloride reabsorption.

  • Result: This increases the excretion of water and salt, reducing the total volume of fluid circulating in the blood.

Technical Synergy: Diuretics can sometimes trigger the body’s Renin-Angiotensin system as a reflex. By adding Losartan, we block that reflex, making the blood pressure reduction much smoother and more potent.

The Manufacturer’s Perspective: Formulation & Export

Producing this FDC in a WHO-GMP facility like yours involves specific technical expertise:

  • Common Strengths: We typically manufacture this in 50/12.5 mg and 100/25 mg ratios.

  • API Stability: Losartan Potassium is hygroscopic (it absorbs moisture from the air). As a firm owner, you know that keeping the humidity strictly controlled in the compression room is vital. We utilize Alu-Alu blister packaging to ensure a 36-month shelf life, especially for export to Zone IVb regions.

  • Content Uniformity: Achieving precise distribution of the smaller HCTZ dose within the larger Losartan matrix requires validated high-shear granulation.

  • B2B & Dossier Support: This is a high-demand item for cardiovascular specialty distributors. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Hyzaar).

What is Losartan Potassium 25 mg used for?

In the pharmaceutical industry, Losartan Potassium 25 mg is a foundational Angiotensin II Receptor Blocker (ARB). As a pharmacist and manufacturer, I classify this as a highly selective, non-peptide antihypertensive. The 25 mg strength is frequently utilized as a starting dose for patients at risk of hypotension or those with hepatic impairment, before titrating up to the standard 50 mg or 100 mg maintenance doses.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): Used to lower blood pressure and reduce the risk of cardiovascular complications like stroke and myocardial infarction.

  • Diabetic Nephropathy: It is a gold-standard treatment for Type 2 diabetic patients with hypertension to delay the progression of kidney disease (proteinuria).

    Left Ventricular Hypertrophy (LVH): Used to reduce the risk of stroke in hypertensive patients with an enlarged heart.

  • Heart Failure: Prescribed for patients who cannot tolerate ACE inhibitors (often due to the “ACE cough”).

Mechanism of Action: Targeted Receptor Blockade

Unlike ACE inhibitors which stop the production of Angiotensin II, Losartan allows it to be produced but blocks its action at the source.

Selective AT1 Blockade: Losartan and its active carboxylic acid metabolite selectively bind to the $AT_1$ receptor found in vascular smooth muscle and the adrenal gland.

Vasodilation: By blocking the binding of Angiotensin II, it prevents vasoconstriction, leading to systemic vasodilation and reduced peripheral resistance.

Aldosterone Inhibition: It blocks the Angiotensin II-stimulated release of aldosterone, reducing sodium and water retention.

No Bradykinin Accumulation: Because it does not inhibit the ACE enzyme, it does not lead to the buildup of bradykinin, which is why it rarely causes the dry cough associated with drugs like Lisinopril.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Losartan Potassium is a high-volume “Essential Medicine”:

  • API Stability: Losartan is a potassium salt, which makes it relatively stable, but it is hygroscopic. As a WHO-GMP manufacturer, we utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • BCS Class III/IV Challenges: Losartan has low permeability and variable solubility. We optimize the particle size distribution (PSD) during granulation to ensure the 25 mg tablet meets the strict dissolution profiles required by BP/USP/IP.

  • Fixed-Dose Combinations (FDCs): For the export market, Losartan is highly successful when combined with Hydrochlorothiazide (HCTZ) or Amlodipine.

  • Dossier & B2B Support: Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Cozaar).

What is Loratadine 10mg used for?

In the pharmaceutical industry, Loratadine 10 mg is a blockbuster second-generation antihistamine. As a pharmacist and manufacturer, I classify Loratadine as a “non-sedating” H1-receptor antagonist. Its major technical advantage over first-generation antihistamines (like Chlorpheniramine) is its inability to cross the blood-brain barrier in significant amounts, providing allergy relief without the intense drowsiness.

Primary Clinical Uses

  • Allergic Rhinitis (Hay Fever): Relieves symptoms such as sneezing, runny nose, and itchy/watery eyes caused by seasonal or perennial allergens (pollen, dust, pet dander).

  • Chronic Urticaria (Hives): Treatment of itchy skin rashes and wheals associated with chronic idiopathic urticaria.

  • Allergic Conjunctivitis: Reduces redness and itching of the eyes due to allergic reactions.

  • Insect Bites: Can be used to manage localized allergic swelling and itching from stings or bites.

Mechanism of Action: Peripheral H1 Blockade

Loratadine works by selectively competing with free histamine for binding at the H1-receptor sites.

Selective Antagonism: It has a high affinity for peripheral H1 receptors found in the respiratory tract, blood vessels, and skin.

Inhibition of the Allergic Cascade: By blocking these receptors, it prevents histamine from causing vasodilation, increased capillary permeability (which causes the runny nose), and nerve stimulation (which causes itching and sneezing).

Long-Acting Profile: Loratadine is metabolized in the liver into Desloratadine, an active metabolite with a very long half-life, allowing for convenient once-daily (24-hour) dosing.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Loratadine 10 mg is a high-volume “Consumer Healthcare” staple:

  • Non-Sedating USP: When promoting this on your digital platforms, the “non-drowsy” profile is your primary marketing angle for B2B buyers looking for worker-safe or student-safe allergy medications.

  • Formulation Stability: Loratadine is relatively stable but sensitive to moisture. At our WHO-GMP facility, we utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia).

  • Dissolution and Bioavailability: We optimize the choice of disintegrants to ensure the 10 mg tablet meets strict BP/USP/IP dissolution standards, ensuring rapid onset of action (typically within 1–3 hours).

  • B2B & Dossier Support: As an essential OTC (Over-The-Counter) product, we provide full CTD/eCTD Dossiers to support international registration against the innovator (Claritin).

What is Loperamide 2mg used for?

In the pharmaceutical industry, Loperamide 2 mg is a synthetic opioid-agonist used as a highly effective anti-diarrheal agent. As a pharmacist and manufacturer, I view Loperamide as a “peripheral-only” medication; while it belongs to the opioid class, it is designed specifically not to cross the blood-brain barrier at therapeutic doses, meaning it treats the gut without affecting the central nervous system.

Primary Clinical Uses

  • Acute Diarrhea: Providing rapid, symptomatic relief for “traveler’s diarrhea” or acute non-specific diarrhea in adults and children over 6 years.

  • Chronic Diarrhea: Management of chronic diarrhea associated with Inflammatory Bowel Disease (IBD), such as Crohn’s disease or Ulcerative Colitis.

  • Ileostomy Output Reduction: Used to reduce the volume of discharge in patients with an ileostomy.

Mechanism of Action: Slowing the Transit

Loperamide works by targeting the $\mu$-opioid receptors located in the myenteric plexus of the intestinal wall.

Reduced Peristalsis: It inhibits the release of acetylcholine and prostaglandins, which decreases the activity of the longitudinal and circular smooth muscles in the intestine.

Increased Transit Time: By slowing down the movement of the gut (peristalsis), it allows more time for the intestines to absorb water and electrolytes from the fecal matter.

Anal Sphincter Tone: It also increases the tone of the anal sphincter, which helps reduce fecal urgency and incontinence.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Loperamide 2 mg is a high-demand “Essential Medicine” with specific technical profiles:

  • Dose Precision: 2 mg is a very small amount of active ingredient. At our WHO-GMP facility in Mumbai, we utilize high-precision blending and validated granulation to ensure absolute content uniformity across every tablet or capsule.

  • Solubility and Dissolution: Loperamide Hydrochloride is poorly soluble in water. We focus on optimized super-disintegrants to ensure the 2 mg dose meets strict BP/USP/IP dissolution standards for rapid onset.

  • Stability for Export: Loperamide is relatively stable but must be protected from high humidity. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa and SE Asia).

  • B2B & Dossier Support: This is a core product for “First Aid” and “Travel Kit” distributors. Our facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Imodium).

Add to cart